+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment for cardiovascular and related diseases

Treatment for cardiovascular and related diseases

Official Gazette of the United States Patent & Trademark Office Patents 1223(3), Jun 15

(PDF 0-2 workdays service: $29.90)

Accession: 035980189

Download citation: RISBibTeXText

Related references

Thienopyridines in the treatment and prevention of cardiovascular diseases. Part V. Combination of clopidogrel and acetylsalicylic acid in the treatment of stable patients with atherothrombotic cardiovascular diseases. Kardiologiia 50(5): 73-76, 2010

Inpatient Case-Related Treatment Costs For Different Cardiovascular Diseases In Germany. Value in Health 17(7): A492-A492, 2014

Cellular senescence in cardiovascular diseases: potential age-related mechanisms and implications for treatment. Current Pharmaceutical Design 19(9): 1710-1719, 2013

Hypoglycaemic and hypolipidemic activities of Balanites aegiptiaca seeds oil An alternative for the treatment of cardiovascular diseases related to diabetes. Diabetes & Metabolism 29(Hors serie 2): 4S144, August, 2003

Age-related gap in the management of heart failure patients. The National Project of Prevention and Treatment of Cardiovascular Diseases--POLKARD. Cardiology Journal 19(2): 146-152, 2013

Study into basic mechanisms of the effects of nitric oxide on cardiovascular system as a basis for pathogenetic treatment of related diseases. Fiziolohichnyi Zhurnal (Kiev) 50(1): 11-30, 2004

Modifying cardiovascular risk factors: epidemiology and characteristics of smoking-related cardiovascular diseases. Current Pharmaceutical Design 16(23): 2504-2509, 2011

Endothelial progenitor cells (EPCs) in ageing and age-related diseases: How currently available treatment modalities affect EPC biology, atherosclerosis, and cardiovascular outcomes. Mechanisms of Ageing and Development 159(): 49-62, 2016

Synthesis of a series of compounds related to betaxolol a new beta 1 adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases. Journal of Medicinal Chemistry 30(6): 1003-1011, 1987

Aging, age-related diseases, and certain risk factors of cardiovascular diseases in subjects of advanced and senile age. Klinicheskaia Meditsina 89(3): 21-27, 2011

Cold-related mortality due to cardiovascular diseases, respiratory diseases and cancer: a case-crossover study. Public Health 127(3): 252-258, 2013

Changes of individual perception in psychosocial stressors related to German reunification in 1989/1990 and cardiovascular risk factors and cardiovascular diseases in a population-based study in East Germany. Bmj Open 6(1): E008703-E008703, 2016

Use of the drug apilak in the treatment of some metabolic and cardiovascular diseases Cardiovascular and metabolic diseases. Use of the drug apilak in the treatment of some metabolic and cardiovascular diseases Cardiovascular and metabolic diseases Primenenie preparata "apilaka" pri lechenii nekotorykh obmennykh i serdechno-sosudistykh zabolevanii In: Serdechno-sosudistye zabolevaniya i bolezni obmena veshchestv Cardiovascular and metabolic diseases 63-69, 1964